| Gland Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543245 |
NSE Symbol : GLAND |
P/E(TTM) : 27.52 |
|
ISIN Demat : INE068V01023 |
Div & Yield% : 0.91 |
EPS(TTM) : 79.87 |
|
Book Value(₹) : 655.32 |
Market Cap(₹Cr) : 36,258.14 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,261.59 | 1,177.51 | 1,074.15 | 1,038.84 | 1,030.35 | 1,010.78 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,261.59 | 1,177.51 | 1,074.15 | 1,038.84 | 1,030.35 | 1,010.78 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 106.36 | 60.21 | 82.59 | 54.74 | 43.72 | 65.06 |
| Total Income | 1,367.95 | 1,237.72 | 1,156.74 | 1,093.58 | 1,074.07 | 1,075.85 |
| Total Expenditure | 753.88 | 780.23 | 699.27 | 679.99 | 636.23 | 619.64 |
| PBIDT | 614.07 | 457.49 | 457.48 | 413.59 | 437.84 | 456.21 |
| Interest | 6.17 | 0.50 | 3.97 | 7.44 | 3.45 | 18.31 |
| PBDT | 607.91 | 456.99 | 453.51 | 406.15 | 434.40 | 437.90 |
| Depreciation | 43.11 | 44.53 | 44.84 | 43.77 | 43.07 | 43.77 |
| Tax | 143.21 | 110.21 | 105.90 | 93.27 | 99.07 | 95.09 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.13 | -5.60 | 0.78 | -0.15 | 2.25 | 3.92 |
| Reported Profit After Tax | 420.45 | 307.85 | 302.00 | 269.26 | 290.00 | 295.12 |
| Extra-ordinary Items | 0.00 | -17.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 420.45 | 325.69 | 302.00 | 269.26 | 290.00 | 295.12 |
| EPS (Unit Curr.) | 25.52 | 18.68 | 18.33 | 16.34 | 17.60 | 17.91 |
| EPS (Adj) (Unit Curr.) | 25.52 | 18.68 | 18.33 | 16.34 | 17.60 | 17.91 |
| Calculated EPS (Unit Curr.) | 25.52 | 18.68 | 18.33 | 16.34 | 17.60 | 17.91 |
| Calculated EPS (Adj) (Unit Curr.) | 25.52 | 18.68 | 18.33 | 16.34 | 17.60 | 17.91 |
| Calculated EPS (Ann.) (Unit Curr.) | 102.08 | 74.74 | 73.32 | 65.37 | 70.41 | 71.65 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 102.08 | 74.74 | 73.32 | 65.37 | 70.41 | 71.65 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.48 | 16.48 | 16.48 | 16.48 | 16.48 | 16.48 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 48.67 | 38.85 | 42.59 | 39.81 | 42.49 | 45.13 |
| PBDTM(%) | 48.19 | 38.81 | 42.22 | 39.10 | 42.16 | 43.32 |
| PATM(%) | 33.33 | 26.14 | 28.12 | 25.92 | 28.15 | 29.20 |
